| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17,7 M € | -5.2% | 18,7 M € | +8.5% | 17,2 M € | +3.1% | 16,7 M € | +5.1% | 15,9 M € | +2.7% | 15,5 M € | -10.6% | 17,3 M € | -6.8% | 18,6 M € | -3.3% | 19,2 M € | -2.9% | 19,8 M € | -7.2% | 21,3 M € | +9.4% | 19,5 M € | -3.6% | 20,2 M € | +2.0% | 19,8 M € | |
| EBITDA | 1,4 M € | +4.2% | 1,4 M € | +2.5% | 1,4 M € | +44.1% | 941,0 k € | -3.8% | 978,2 k € | +15.1% | 849,7 k € | -11.0% | 954,3 k € | -4.2% | 996,3 k € | +20.6% | 826,0 k € | -59.2% | 2,0 M € | +167.4% | 757,2 k € | -66.4% | 2,3 M € | -13.3% | 2,6 M € | -7.0% | 2,8 M € | |
| Operating profit | 768,1 k € | -1.4% | 779,3 k € | -5.5% | 824,7 k € | +59.3% | 517,6 k € | -13.3% | 597,3 k € | -5.6% | 632,9 k € | -8.3% | 690,2 k € | -11.5% | 780,0 k € | +24.2% | 628,1 k € | -60.1% | 1,6 M € | +354.0% | 346,5 k € | -80.3% | 1,8 M € | -10.4% | 2,0 M € | -16.4% | 2,4 M € | |
| Profit/loss | 475,2 k € | +1.5% | 468,2 k € | -12.2% | 533,4 k € | +76.1% | 302,9 k € | -12.3% | 345,3 k € | -6.3% | 368,3 k € | +3.9% | 354,5 k € | +7.1% | 330,9 k € | +10.1% | 300,7 k € | -68.2% | 945,8 k € | +563.5% | 142,6 k € | -87.2% | 1,1 M € | -10.7% | 1,2 M € | -14.2% | 1,5 M € | |
| Equity | 3,1 M € | -25.1% | 4,1 M € | -0.0% | 4,1 M € | -26.4% | 5,5 M € | +5.8% | 5,2 M € | +7.0% | 4,9 M € | -25.0% | 6,5 M € | +5.7% | 6,2 M € | +5.7% | 5,8 M € | -57.4% | 13,7 M € | +7.4% | 12,8 M € | +1.1% | 12,6 M € | +9.7% | 11,5 M € | +12.2% | 10,3 M € | |
| Total assets | 7,7 M € | -6.4% | 8,3 M € | -8.7% | 9,1 M € | +4.0% | 8,7 M € | +4.7% | 8,3 M € | -19.9% | 10,4 M € | +10.1% | 9,4 M € | -12.6% | 10,8 M € | +0.6% | 10,7 M € | -37.7% | 17,2 M € | -6.4% | 18,4 M € | +17.8% | 15,6 M € | +5.4% | 14,8 M € | +16.4% | 12,7 M € | |
| Cash | 2,1 k € | -40.4% | 3,5 k € | +115.5% | 1,6 k € | -31.7% | 2,4 k € | -91.1% | 26,9 k € | -1.7% | 27,4 k € | -26.6% | 37,3 k € | +360.2% | 8,1 k € | -99.2% | 1,0 M € | +32.8% | 773,5 k € | +6.1% | 729,2 k € | -38.7% | 1,2 M € | -65.3% | 3,4 M € | +36.5% | 2,5 M € | |
| Debts | 4,7 M € | +11.8% | 4,2 M € | -15.7% | 5,0 M € | +57.7% | 3,2 M € | +2.9% | 3,1 M € | -44.0% | 5,5 M € | +89.0% | 2,9 M € | -37.2% | 4,6 M € | -3.9% | 4,8 M € | +39.9% | 3,4 M € | -31.3% | 5,0 M € | +73.7% | 2,9 M € | -12.9% | 3,3 M € | +33.9% | 2,5 M € | |
| Staff | 74,6 | 75,2 | 72,9 | 74,4 | 72,2 | 71,7 | 74,1 | 73,4 | 69,8 | 75 | 78,2 | 78,8 | 77,2 | 73,8 | ||||||||||||||
Public limited company · Erpe-Mere · incorporated on 08/12/1978 · 74,6 ETP
Public limited company profitable and well capitalised. Cash position declining (-40.4%).
Solid counterparty for a standard engagement.
Arjo Belgium is a Public limited company incorporated in 1978. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Erpe-Mere. It employs on average 74,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette